95
Views
3
CrossRef citations to date
0
Altmetric
BIOANALYTICAL

Voltammetric Application of Polypyrrole-Modified Microelectrode Array for the Characterization of DNA Methylation in Glutathione S-Transferase Pi 1

, &
Pages 2614-2627 | Received 30 Nov 2017, Accepted 03 Feb 2018, Published online: 28 Mar 2018

References

  • Aiyejorun, T., L. Thompson, J. Kowalik, M. Josowicz, and J. Janata. 2005. Control of chloride ion exchange by DNA hybridization at polypyrrole electrode. In Perspectives in bioanalysis, ed. E. Paleček, F. Scheller, and J. Wang, vol. 1, 331–44. Cambridge, MA: Elsevier. doi:10.1016/S1871-0069(05)01009-8.
  • Antequera, F., and A. Bird. 1999. CpG Islands as genomic footprints of promoters that are associated with replication origins. Current Biology 9:661–67. http://biomednet.com/elecref/09609822009R0661.
  • Bohnen, A. M., F. P. Groeneveld, and J. L. H. R. Bosch. 2007. Serum prostate-specific antigen as a predictor of prostate volume in the community: The Krimpen study. European Urology 51 (6):1645–53. doi:10.1016/j.eururo.2007.01.084.
  • Cagnin, S., M. Caraballo, C. Guiducci, P. Martini, M. Ross, M. SantaAna, D. Danley, T. West, and G. Lanfranchi. 2009. Overview of electrochemical DNA biosensors: New approaches to detect the expression of life. Sensors 9 (4):3122–48. doi:10.3390/s90403122.
  • Chou, R., J. M. Croswell, T. Dana, C. Bougatsos, I. Blazina, R. Fu, K. Gleitsmann, H. C. Koenig, C. Lam, A. Maltz, J. B. Rugge, and K. Lin. 2011. Screening for prostate cancer: A review of the evidence for the U.S. preventive services task force. Annals of Internal Medicine 155 (11):762. doi:10.7326/0003-4819-155-11-201112060-00375.
  • Drummond, T. G., M. G. Hill, and J. K. Barton. 2003. Electrochemical DNA sensors. Nature Biotechnology 21 (10):1192–99. doi:10.1038/nbt873.
  • Epigentek. 2015. BisulFlash™ DNA modification kit. https://www.epigentek.com/docs/P-1026.pdf.
  • Frommer, M., L. E. McDonald, D. S. Millar, C. M. Collis, F. Watt, G. W. Grigg, P. L. Molloy, and C. L. Paul. 1992. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proceedings of the National Academy of Sciences of the United States of America 89 (5):1827–31. http://www.ncbi.nlm.nih.gov/pubmed/1542678.
  • Harden, S. V., Z. Guo, J. I. Epstein, D. Sidransky, S. Nagubadi, and P. Guinan. 2003. Quantitative Gstp1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma. The Journal of Urology 169 (3):1138–42. doi:10.1097/01.ju.0000049627.90307.4d.
  • Hartung, J., J. Kowalik, C. Kranz, J. Janata, M. Josowicz, A. Sinha, and K. McCoy. 2005. Electropolymerization of bilayer with phosphonic acid tethers for immobilization of biomolecules. Journal of the Electrochemical Society 152 (11):E345. doi:10.1149/1.2041868.
  • Hayatsu, H., Y. Wataya, and K. Kazushige. 1970. The addition of sodium bisulfite to uracil and to cytosine. Journal of the American Chemical Society 92 (3):724–26. http://www.ncbi.nlm.nih.gov/pubmed/5411063.
  • Herman, J. G., J. R. Graff, S. Myohanen, B. D. Nelkin, and S. B. Baylin. 1996. Methylation-specific PCR : A novel PCR assay for methylation status of CpG Islands. Proceedings of the National Academy of Sciences 93 (September):9821–26.
  • Hessels, D., and J. A. Schalken. 2013. Urinary biomarkers for prostate cancer: A review. Asian Journal of Andrology 156:333–39. http://hdl.handle.net/2066/117921.
  • Hoque, M. O., O. Topaloglu, S. Begum, R. Henrique, E. Rosenbaum, W. Van Criekinge, W. H. Westra, and D. Sidransky. 2005. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 23 (27):6569–75. doi:10.1200/JCO.2005.07.009.
  • Jain, S., T. K. Wojdacz, and Y.-H. Su. 2013. Challenges for the application of DNA methylation biomarkers in molecular diagnostic testing for cancer. Expert Review of Molecular Diagnostics 13 (3):283–94. doi:10.1586/erm.13.9.
  • Jerónimo, C., H. Usadel, R. Henrique, J. Oliveira, C. Lopes, W. G. Nelson, and D. Sidransky. 2001. Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. Journal of the National Cancer Institute 93 (22):1747–52. http://www.ncbi.nlm.nih.gov/pubmed/11717336.
  • Jerónimo, C., H. Usadel, R. Henrique, C. Silva, J. Oliveira, C. Lopes, and D. Sidransky. 2002. Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer. Urology 60 (6):1131–35. doi:10.1016/S0090-4295(02)01949-0.
  • Kalantari, R., R. Cantor, H. Chen, G. Yu, J. Janata, and M. Josowicz. 2010. Label-free voltammetric detection using individually addressable oligonucleotide microelectrode arrays. Analytical Chemistry 82 (21):9028–33. doi:10.1021/ac102002k.
  • Kerman, K., K. Masaaki, and T. Eiichi. 2004. Recent trends in electrochemical DNA biosensor technology. Measurement Science and Technology 15:R1–11. doi:10.1088/0957-0233/15/2/R01.
  • Lippi, G., M. Montagnana, G. C. Guidi, and M. Plebani. 2009. Prostate-specific antigen-based screening for prostate cancer in the third millennium: Useful or hype? Annals of Medicine 41 (7):480–89. doi:10.1080/07853890903156468.
  • Martienssen, R. 1995. DNA methylation in eukaryotes. Current Opinion in Genetics & Development 5 (2):234–42. doi:10.1016/0959-437X(95)80014-X.
  • Moyer, V., and USPTF Services. 2012. Screening for prostate cancer: U.S. preventive services task force recommendation statement. Annals of Internal Medicine 157:120–34.
  • Nelson, W. G., A. M. De Marzo, T. L. Deweese, X. Lin, J. D. Brooks, M. J. Putzi, C. P. Nelson, J. D. Groupman, and T. W. Kensler. 2001. Preneoplastic prostate lesions. Annals of the New York Academy of Sciences 952 (1):135–44. doi:10.1111/j.1749-6632.2001.tb02734.x.
  • Nian, J., X. Sun, S. Ming, C. Yan, Y. Ma, Y. Feng, L. Yang, M. Yu, G. Zhang, and X. Wang. 2017. Diagnostic accuracy of methylated SEPT9 for blood-based colorectal cancer detection: A systematic review and meta-analysis. Clinical and Translational Gastroenterology 8 (1):e216. doi:10.1038/ctg.2016.66.
  • Odenthal, K. J., and J. J. Gooding. 2007. An introduction to electrochemical DNA biosensors. Analyst 132 (7):603–10. doi:10.1039/b701816a.
  • Paleček, E., and M. Bartošík. 2012. Electrochemistry of nucleic acids. Chemical Reviews 112 (6):3427–81. doi:10.1021/cr200303p.
  • Paziewska, A., M. Dabrowska, K. Goryca, A. Antoniewicz, J. Dobruch, M. Mikula, D. Jarosz, L. Zapala, A. Borowka, and J. Ostrowski. 2014. DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy. British Journal of Cancer 111 (4):781–89. doi:10.1038/bjc.2014.337.
  • Saheb, A. H., M. Leon, and M. Josowicz. 2012. Electrochemical assay of GSTP1-related DNA sequence for prostate cancer screening. The Electrochemical Society, Interface 21 (3–4):71–75. https://www.electrochem.org/dl/interface/fal/fal12/fal_win12_p071_075.pdf.
  • Saheb, A., S. Patterson, and M. Josowicz. 2014. Probing for DNA methylation with a voltammetric DNA detector. The Analyst 139 (4):786–92. doi:10.1039/C3AN02154H.
  • Saheb, A., S. Patterson, M. Josowicz, J. Kamradt, A. Strauss, P. Thelen, F. Model, J. K. Day, V. Liebenberg, A. Morotti, et al. 2014. Probing for DNA methylation with a voltammetric DNA detector. The Analyst 139 (4):786–92. doi:10.1039/C3AN02154H.
  • Siddiquee, S., N. A. Yusof, A. B. Salleh, F. A. Bakar, and L. Y. Heng. 2010. Electrochemical DNA biosensor for the detection of specific gene related to Trichoderma harzianum species. Bioelectrochemistry 79 (1):31–36. doi:10.1016/j.bioelechem.2009.10.004.
  • Siegel, R., D. Naishadham, and A. Jemal. 2012. Cancer statistics, 2012. Cancer Journal for Clinicians 62 (1). doi:10.3322/caac.20138.
  • Thompson, L. A., J. Kowalik, M. Josowicz, and J. Janata. 2003. Label-free DNA hybridization probe based on a conducting polymer. Journal of the American Chemical Society 125 (2):324–25. doi:10.1021/ja027929z.
  • Wallner, L. P., S. J. Jacobsen, C. P. Quesenberry, N. S. Weiss, H. Wilcox, and S. J. Jacobsen. 2013. Prostate-specific antigen and prostate cancer mortality. American Journal of Preventive Medicine 45 (3):318–26. doi:10.1016/j.amepre.2013.04.015.
  • Wang, J. 2006. Electrochemical biosensors : Towards point-of-care cancer diagnostics. Biosensors and Bioelectronics 21 (July 2005):1887–92. doi:10.1016/j.bios.2005.10.027.
  • WebMD. n.d. Prostate cancer screening (PDQ): Screening - Health professional information [NCI]-evidence of benefit. WebMD. Rockville, MD.
  • Woodson, K., K. J. O’Reilly, J. C. Hanson, D. Nelson, E. L. Walk, and J. A. Tangrea. 2008. The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer. The Journal of Urology 179 (2):508–12. doi:10.1016/j.juro.2007.09.073.
  • Wu, T., E. Giovannucci, J. Welge, P. Mallick, W. Tang, and S. Ho. 2011. Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening : A meta-analysis. British Journal of Cancer 105 (1):65–73. doi:10.1038/bjc.2011.143.
  • Zhang, Y., C. Rohde, S. Tierling, H. Stamerjohanns, R. Reinhardt, J. Walter, and A. Jeltsch. 2009. DNA methylation analysis by bisulfite conversion, cloning, and sequencing of individual clones. In DNA methylation, ed. Jörg Tost, 177–87. Totowa, NJ: Humana Press. doi:10.1007/978-1-59745-522-0_14.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.